A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Clinical trial NCT01076517 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01076517
- Sponsor
- Stanford University
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.